Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
191 hedge funds and large institutions have $915M invested in Meridian Bioscience Inc in 2020 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 58 increasing their positions, 55 reducing their positions, and 29 closing their positions.
270% more call options, than puts
Call options by funds: $3.86M | Put options by funds: $1.04M
203% more capital invested
Capital invested by funds: $302M → $915M (+$613M)
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
79% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 29
14% more funds holding
Funds holding: 168 → 191 (+23)
5% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 55
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$24.1M |
| 2 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$15.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.3M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$9.4M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$5.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$9.05M |
| 2 |
Millennium Management
New York
|
-$7.06M |
| 3 |
D.E. Shaw & Co
New York
|
-$6.8M |
| 4 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$5.3M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$5.1M |
VIVO Hedge Fund Activity: Q2 2020 in Review
191 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2020, worth a combined $915M — up 203% from $302M a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new VIVO positions and 29 closed out — a net gain of 23 holders — while 58 added to existing stakes and 55 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $24.1M. The largest seller was JP Morgan Chase, cutting an estimated $9.05M.
- 191 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2020, up from 168 in Q1 2020.
- Funds reported $915M of Meridian Bioscience Inc stock for Q2 2020, up 203% quarter-over-quarter.
- 52 funds opened new Meridian Bioscience Inc positions in Q2 2020 and 29 closed out, a net change of +23 holders.
- The largest Meridian Bioscience Inc buyer in Q2 2020 was Deerfield Management, an estimated $24.1M added.
- The largest Meridian Bioscience Inc seller in Q2 2020 was JP Morgan Chase, an estimated $9.05M sold.
Based on aggregated 13F filings for Q2 2020.